Arbutus to Receive $116 Million Strategic Investment from Roivant Sciences
Oct 02, 2017 11:01 am UTC| Business
Cash to Provide Significant Support for Arbutus to Fund HBV RD PipelineRoivant to Support Accelerating Development of Arbutus’ HBV Pipeline and Maximizing the Value of Arbutus’ LNP Assets VANCOUVER, British Columbia and...
uniQure Announces Company Presentations at Upcoming October Conferences
Oct 02, 2017 11:01 am UTC| Business
LEXINGTON, Mass. and AMSTERDAM, the Netherlands, Oct. 02, 2017 -- uniQure N.V. (NASDAQ:QURE) a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced...
Government of Mexico to Honor Ralph de la Vega at USHCC National Convention
Oct 02, 2017 11:01 am UTC| Business
Washington, D.C., Oct. 02, 2017 -- The United States Hispanic Chamber of Commerce (USHCC) is proud to announce former Vice Chairman of ATT Inc. and CEO of Business Solutions International, Ralph de la Vega, as the...
Oct 02, 2017 11:00 am UTC| Business
Top-line data expected in Q1 2018 TEL AVIV, Israel, Oct. 02, 2017 -- VBL Therapeutics (NASDAQ:VBLT), today announced that the independent Data Safety Monitoring Committee (DSMC) met on September 28, 2017 to conduct...
Oct 02, 2017 11:00 am UTC| Business
Reno, Oct. 02, 2017 -- Enhance Skin Products Inc. (OTCBB: EHSK), today announced that it has placed its Consolidated Financial Statements for the period to April 30, 2017 (Unaudited) on its website...
Brookfield Renewable Announces Quarterly Dividend Rate on Its Series 2 Preference Shares
Oct 02, 2017 11:00 am UTC| Business
All amounts in Canadian dollars unless otherwise stated BROOKFIELD, News, Oct. 02, 2017 -- Brookfield Renewable Partners L.P. (TSX:BEP.UN) (NYSE:BEP) (“Brookfield Renewable”) today announced the quarterly dividend on...
Assembly Biosciences Announces 2017 AASLD Presentations
Oct 02, 2017 11:00 am UTC| Business
INDIANAPOLIS, Oct. 02, 2017 -- Assembly Biosciences, Inc. (NASDAQ:ASMB), a clinical-stage biotechnology company advancing a new class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel...